Pre-Clinical CROs Market to Reach US$ 8,412.9 Mn at a CAGR of 8.1% in 2027 | The Insight Partners

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geography

Publication Month: Sep 2019 | Report Code: TIPRE00003316 | No. of Pages: 139 | Category: Pharmaceuticals | Status: Published

The global pre-clinical CROs market expected to be US$ 4,282.42 Mn in 2018 and is predicted to grow at a CAGR of 8.1% during the forecast period 2019 – 2027, to reach US$ 8,412.9 Mn by 2027.

 

Europe is the second largest geographic market and is expected to be the second most significant revenue contributor throughout the forecast period. Increasing number of clinical trials, presence of prominent players in the CROs market, and rapid growth in the pharmaceutical companies are likely to be the major factors driving the growth of this market in the European region

 

Exhibit: Lucrative Regional Pre-Clinical CROs Markets


 

Market Insights

Higher Cost of Drug Development Process in Developed Countries

A rise in outsourcing activities by pharmaceutical companies has been witnessed during recent years. This trend has been seen as a plan to remain competitive and flexible in a market of exponential growth, sophisticated technologies, and an unstable economic environment. Companies generally outsource R&D tasks which include a broad range of activities such as, fundamental research to late-stage development: hit exploration and lead optimization, target validation, genetic engineering, assay development, safety and efficacy tests in animal models, and clinical trials which involve humans.

 

The major factors driving the growth of outsourcing activities by companies are, cutting costs, need for innovations, increased speed and agility, and accessing specialized knowledge and technologies. A decreasing percentage of profits has become a primary concern for pharmaceutical companies over the past decade. As per an analysis by PhRMA, around $0.8 to $1.7 billion is estimated to be invested by the pharmaceutical industry in R&D to bring a new drug to market. Hence, with an increase in the R&D expenditure, the need for pre-clinical services is expected.

 

Increasing Number of Clinical Trials

Clinical trials are a vital step in discovering whether the medical strategy, treatment, or device is safe and effective for human use. It is one of the engines that drive innovation in the biopharmaceutical sector. Clinical studies help in understanding as well as determining the most suitable medical approaches for a particular therapeutic area. These trials are conducted primarily to collect data regarding the safety and efficacy of a new drug and device development. Before the approval of molecules and medical devices by the regulatory authorities, a series of clinical studies are carried out. Increasing prevalence of chronic diseases is increasing the demand for the development of new drugs or medical devices for the treatment. According to a report published by Seeker Health, at any given point, there are approximately 6000 clinical trials for which patients enroll across the globe. This is in turn expected to increase the demand of the clinical trial activities for various therapeutic areas, hence driving the growth of the pre-clinical CROs market.

 

Service Insights

The global pre-clinical CROs market by service was segmented as, bio-analysis & DMPK studies, toxicology, and other services. In 2018, toxicology segment held the largest share of the market. The in-vitro and in-vivo toxicology services helps to bolster the ability of determination of potential risk factors in the early process of drug development. The toxicology studies are required to establish the toxicological profiles of new drug molecules prior to their administration in humans.

 

Exhibit: Pre-Clinical CROs Market, by Product


 

PRE-CLINICAL CROS – MARKET SEGMENTATION

 

By Service

  • Bio-Analysis and DMPK Studies
  • Toxicology
  • Other Services 

By End User

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • Covance Inc. (LabCorp)
  • Charles River Laboratories, Inc.
  • Eurofins Advinus Limited
  • PRA Health Sciences
  • WuXi AppTec Group
  • Medpace, Inc.
  • Pharmaceutical Product Development, LLC
  • Parexel International
  • ICON plc
  • MD Biosciences, Inc.

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Global Pre-Clinical CROs Market – By Service

1.3.2       Global Pre-Clinical CROs Market – By End User

1.3.3       Global Pre-Clinical CROs Market – By Geography

2.             Global Pre-Clinical CROs Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Pre-Clinical CROs Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       North America PEST Analysis

4.2.2       Europe PEST Analysis

4.2.3       Asia Pacific PEST Analysis

4.2.4       Middle East & Africa PEST Analysis

4.2.5       South & Central America PEST Analysis

4.3       Expert Opinions

5.             Global Pre-Clinical CROs Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1       Increasing R&D Expenditures

5.1.2       Higher Cost of Drug Development Process in Developed Countries

5.2       Key Market Restraint

5.2.1       Dearth of Skilled Professionals

5.3       Key Market Opportunities

5.3.1       Rising Biosimilars and Biologics Market

5.4       Future Trends

5.4.1       Increasing Number of Clinical Trials

5.5       Impact Analysis

6.             Pre-Clinical CROs Market – Global Analysis

6.1       Global Pre-Clinical CROs Market Revenue Forecasts And Analysis

6.2       Global Pre-Clinical CROs Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Global Pre-Clinical CROs Market Analysis– by Service

7.1       Overview

7.2       Global Pre-Clinical CROs Market, By Service 2018 & 2027 (%)

7.3       Bio-Analysis and DMPK Studies Market

7.3.1       Overview

7.3.2       Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3       Toxicology Market

7.3.3.1    Overview

7.3.3.2    Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4       Other Services Market

7.3.4.1    Overview

7.3.4.2    Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Global Pre-Clinical CROs Market Analysis – by End User

8.1       Overview

8.2       Global Pre-Clinical CROs Market, By End User 2018 & 2027 (%)

8.3       Biopharmaceutical Companies Market

8.3.1       Overview

8.3.2       Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Government & Academic Institutes Market

8.4.1       Overview

8.4.2       Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Medical Device Companies Market

8.5.1       Overview

8.5.2       Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Pre-Clinical CROs Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1       North America Pre-Clinical CROs Market

9.1.1       Overview

9.1.2       North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3       North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.4       North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5       North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.1.6       US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1    US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2    US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.6.3    US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7       Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2    Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.7.3    Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8       Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1    Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2    Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.8.3    Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2       Europe Pre-Clinical CROs Market

9.2.1       Overview

9.2.2       Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3       Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.4       Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.5       Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.2.6       UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1    UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2    UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.6.3    UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.7       Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1    Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2    Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.7.3    Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.8       France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1    France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2    France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.8.3    France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.9       Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1    Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2    Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.9.3    Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.10    Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.1  Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.2  Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.10.3  Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3       Asia Pacific Pre-Clinical CROs Market

9.3.1       Overview

9.3.2       Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3       Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.4       Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.5       Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.3.6       China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1    China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2    China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.6.3    China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7       India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1    India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2    India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.7.3    India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.8       Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1    Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2    Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.8.3    Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.9       Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1    Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.2    Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.9.3    Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.10    South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.1  South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.2  South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.10.3  South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4       Middle East & Africa Pre-Clinical CROs Market

9.4.1       Overview

9.4.2       Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.3       Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.4       Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.5       Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.4.6       South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1    South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.2    South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.6.3    South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.7       Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.1    Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.2    Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.7.3    Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.8       UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1    UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.2    UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.8.3    UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5       South And Central America Pre-Clinical CROs Market

9.5.1       Overview

9.5.2       South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3       South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service  (US$ Mn)

9.5.4       South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

9.5.5       South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.5.6       Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.1    Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.2    Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.6.3    Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.7       Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1    Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.2    Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.7.3    Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.          Pre-Clinical CROs Market – Industry Landscape

10.1    Overview

10.2    Growth Strategies in the Pre-Clinical CROs Market, 2016-2019

10.3    Organic Growth Strategies

10.3.1    Overview

10.4    Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)

10.4.1    Expansion & Other Activities

10.4.1.1  Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market

10.4.2    Product Launches

10.4.2.1  Recent Product Launches By Players In The Pre-Clinical CROs Market

10.5    Inorganic Growth Strategies

10.5.1    Overview

10.6    Inorganic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)

10.6.1    Acquisitions

10.6.1.1  Recent Acquisitions By Players In The Pre-Clinical CROs Market

10.6.2    Agreements & Collaborations

10.6.2.1  Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market

10.6.3    Partnerships

10.6.3.1  Recent Partnerships By Players In The Pre-clinical CROs Market

11.          Pre-Clinical CROs Market–Key Company Profiles

11.1    MD Biosciences, Inc.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Services Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    WuXi AppTec

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Service Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Pharmaceutical Product Development, LLC.

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Service Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Covance Inc.

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Information

11.4.4    Service Portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Charles River

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Services Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    PRA Health Sciences, Inc.

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Overview

11.6.4    Service Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Medpace

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Service Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Parexel International Corporation

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Information

11.8.4    Service Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    ICON Plc

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Service Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Eurofins Scientific

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms


LIST OF TABLES

Table 1.            R&D Investments by Major Pharmaceutical Companies

Table 2.            R&D Investments by PhRMA Member Companies,2016

Table 3.            Number of Studies Registered for Clinical Trials

Table 4.            North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 5.            North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 6.            US: R&D Investments by Pharmaceutical Companies, (2015-2016)

Table 7.            US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 8.            US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9.            Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 10.         Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 11.         Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 12.         Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13.         Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 14.         Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 15.         UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 16.         UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17.         Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 18.         Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 19.         France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 20.         France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21.         Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 22.         Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 23.         Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 24.         Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25.         Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 26.         Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 27.         China: Major global pharmaceutical companies by R&D investments, 2013

Table 28.         China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 29.         China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 30.         India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 31.         India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 32.         India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 33.         Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 34.         Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 35.         Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 36.         Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37.         South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 38.         South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 39.         Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 40.         Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 41.         South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 42.         South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 43.         Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 44.         Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 45.         UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 46.         UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 47.         South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 48.         South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49.         Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 50.         Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 51.         Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 52.         Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 53.         Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market

Table 54.         Recent Product Launches in the Pre-Clinical CROs Market

Table 55.         Recent Acquisitions By Players In The Pre-Clinical CROs Market

Table 56.         Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market

Table 57.         Recent Partnerships By Players In The Pre-clinical CROs Market

Table 58.         Glossary of Terms, Pre-Clinical CROs Market

LIST OF FIGURES

Figure 1.          Pre-Clinical CROs Market Segmentation

Figure 2.          Pre-Clinical CROs Market Segmentation, by Region

Figure 3.          Global Pre-Clinical CROs Market Overview

Figure 4.          Imaging Segment Held Largest Share Of The Service Segment In Pre-Clinical CROs Market

Figure 5.          Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6.          Global Pre-Clinical CROs Market, By Geography (US$ Mn)

Figure 7.          Global Pre-Clinical CROs Market- Leading Country Markets (US$ Mn)

Figure 8.          Global Pre-Clinical CROs Market, Industry Landscape

Figure 9.          North America : PEST Analysis

Figure 10.       Europe: PEST Analysis

Figure 11.       Asia - Pacific: PEST Analysis

Figure 12.       Middle East & Africa: PEST Analysis

Figure 13.       South & Central America: PEST Analysis

Figure 14.       Number of Approvals for NDA & BLA (2005 to 2016)

Figure 15.       Impact Analysis of Driver and Restraints Pertaining to Pre-Clinical CROs Market

Figure 16.       Global Pre-Clinical CROs Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 17.       Global Pre-Clinical CROs Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 18.       Prominent Players in the Pre-Clinical CROs Market

Figure 19.       Global Pre-Clinical CROs Market, by Service 2018 & 2027 (%)

Figure 20.       Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       Global Pre-Clinical CROs Market, by End User 2018 & 2027 (%)

Figure 24.       Global Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       North America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 28.       North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 30.       US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.       Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       Europe Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 34.       Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 36.       UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.       France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.       Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Asia Pacific Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 42.       Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 44.       China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.       Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.       South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       Middle East & Africa Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 50.       Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 52.       South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.       Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.       UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.       South and Central America Pre-Clinical CROs Market Revenue, by Country, 2018 (US$ Mn)

Figure 56.       South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

Figure 58.       Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.       Growth Strategies in the Pre-Clinical CROs Market, 2016-2019

Figure 61.       Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)

Figure 62.       Inorganic Developments in the Pre-Clinical CROs Market, 2016-2019(%)

 

The List of Companies

  1. Covance, Inc.
  2. Charles River
  3. Eurofins Scientific
  4. PRA Health Sciences
  5. WuXi AppTec
  6. Medpace, Inc.
  7. Pharmaceutical Product Development, LLC
  8. Parexel International Corporation
  9. ICON Plc
  10. MD Biosciences
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pre-clinical CROs market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global pre-clinical CROs market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.